Cargando…
Utilization and spending trends for antiretroviral medications in the U.S. Medicaid program from 1991 to 2005
BACKGROUND: HIV/AIDS incidence and mortality rates have decreased in the U.S. since 1996. Accompanying the longer life spans of those diagnosed with the disease, however, is a tremendous rise in expenditures on medication. The objective of this study is to describe the trends in utilization of, spen...
Autores principales: | Jing, Yonghua, Klein, Patricia, Kelton, Christina ML, Li, Xing, Guo, Jeff J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2147021/ https://www.ncbi.nlm.nih.gov/pubmed/17937821 http://dx.doi.org/10.1186/1742-6405-4-22 |
Ejemplares similares
-
Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years’ Experience 1991–2015
por: Almalki, Ziyad S., et al.
Publicado: (2016) -
ACE Inhibitor and ARB Utilization and Expenditures in the Medicaid Fee-For-Service Program from 1991 to 2008
por: Bian, Boyang, et al.
Publicado: (2010) -
Intergenerational enrollment and expenditure changes in Medicaid: trends from 1991 to 2005
por: Patrick, Stephen W, et al.
Publicado: (2012) -
Spending, Utilization, and Price Trends for Immune Checkpoint Inhibitors in US Medicaid Programs: An Empirical Analysis from 2011 to 2021
por: Shin, Young Eun, et al.
Publicado: (2023) -
Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval
por: Sachs, Rachel E., et al.
Publicado: (2021)